Home | About Us | Therapies | Platform | Leadership | Lactose Intolerance | News | Contact Us | Site Map
© Copyright 2013 Ritter Pharmaceuticals. All Rights Reserved
CEO Andrew Ritter won the grand prize and audience favorite awards in the Tech Coast Angels’ 4th annual Quick Pitch Competition. The Quick Pitch Competition featured 14 finalists who each gave a brief presentation on their business investment opportunity in front of a panel of industry judges and an audience of over 500 leaders within the entrepreneurial community.
Mr. Ritter focused his presentation on the company’s flagship product, RP-G28, which is being developed as the first prescription drug to treat lactose intolerance long-term. His presentation not only won the grand prize, but also overwhelmingly won the audience popular vote.







Leave Your Response